Delivery Order SPE2DB22D3301-SPE2DB26FX3UT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,060.79 to AmerisourceBergen Drug Corp for the supply of DARZALEX 400 mg/20 mL vials. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating the contract was competed among qualified vendors in the open market. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the drug DARZALEX 400 MG/20 ML VIAL 20ML. The $15,511.12 contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. The contract was awarded under a larger indefinite delivery contract (IDC) with a potential value of...
- The Defense Logistics Agency awarded a $87,253.24 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This firm fixed-price, non-set-aside contract is set to be completed by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,930.09 to AmerisourceBergen Drug Corp for the supply of Darzalex 400 mg/20 mL vials. This firm fixed-price delivery order, issued on May 8, 2025, carries an ultimate completion date of May 30, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The U.S. Department of Defense Medical Supply Chain awarded a $71,762.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPR 1800 1S on September 4, 2025, with completion targeted for September 25, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. The vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $119,604.20 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, was competitively awarded with no set-aside designation. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $149,505.25 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed price contract, awarded September 26, 2025, with an ultimate completion date of October 20, 2025, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a $107,643.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3UTDelivery Order
The Defense Logistics Agency awarded a $6,747.72 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of DARZALEX 400 mg/20 ml vials. The contract, which is scheduled for completion by November 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location at the same address. This delivery order falls under the company's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026 that enables AmerisourceBergen to serve military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for defense and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products, brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. All reviewed contract awards demonstrate the company's capability to meet federal procurement requirements through open competition with firm fixed pricing arrangements, positioning AmerisourceBergen as a key supplier for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 10/24/25 |